Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial

https://www.thelancet.com/collections/psychiatry?dgcid=hubspot_email_infocusalerts-psychiatry_feature%20&parent=001633&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-8bARN9A33qLsCBDsqeRd39ofi6CuxpHjxgbLWszhNpSArUiY6IB7NaFjppOJ3sCrFMMXlbLfQl6Jel1_mUrb7VKiw8sw&_hsmi=344118207&utm_content=343602217&utm_source=hs_email